Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
disease modification in lupus nephritis towards a pathophysiology based treatment paradigm
Original title: “Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm.”
early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis a multicenter propensity matched study
Original title: “Early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis: a multicenter propensity-matched study.”
epidemiology and prognosis of childhood lupus nephritis in the afro descendant population of the french overseas departments of america
Original title: “Epidemiology and prognosis of childhood lupus nephritis in the Afro-descendant population of the French Overseas Departments of America.”
case of lupus nephritis combined with fibrillary glomerulonephritis diagnosed using mass spectrometry and immunohistochemistry of dnajb9
Original title: “A case of lupus nephritis combined with fibrillary glomerulonephritis diagnosed using mass spectrometry and immunohistochemistry of DNAJB9.”